{"id":751462,"date":"2023-04-26T11:21:31","date_gmt":"2023-04-26T15:21:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/"},"modified":"2023-04-26T11:21:31","modified_gmt":"2023-04-26T15:21:31","slug":"corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/","title":{"rendered":"Corza Medical Signs Definitive Agreement to Acquire Takeda&#8217;s TachoSil Manufacturing Operations"},"content":{"rendered":"<div class=\"mw_release\">\n<p \/>\n<p align=\"left\">WESTWOOD, Mass., April  26, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iQyq2DWP0NeM7t61wOVs1mk8bTkVJuMQfZcoUaZ_-h5xd7Dl-ip_WC4MHUctLFGvz3grMNI8z7QpcfxycI3TEQ==\" rel=\"nofollow noopener\" target=\"_blank\">Corza Medical<\/a> announced today that it has entered into a definitive agreement with a subsidiary of Takeda Pharmaceuticals Company (TSE:4502\/NYSE:TAK) (\u201cTakeda\u201d) to acquire the TachoSil manufacturing operations in Linz, Austria. Corza Medical had <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cjEp1J4tVMLPw9wrpU9kBEBXvhHkEKzEBIWoaCSwBNOajLPzmvztPz_CzvftCb7pWxUzyQWVLG3b0X5xYEU-Guawqcr66oTWzcDJvVVkDzSD5ieexNPlVN5Hi2mxFaxynmW0FHyzA7fpSbv3RMVD8_ICiCWNp2srdDtFTCnDVd_k9yz4dCJTJQonz2SZaGq6YRGaf6JJKzVSaoUNd0rREU6YWCwlbINLeOEZAZua9_GbgGWKzmrK0DXyKtMTVThZ9WpV5RdSK9fDIZPI839Xbw==\" rel=\"nofollow noopener\" target=\"_blank\">previously acquired the commercial product rights for TachoSil<\/a>, a best-in-class surgical patch trusted by medical professionals worldwide, in January 2021. Corza Medical shares Takeda\u2019s commitment to patient care and has the experience and resources to continue investing in TachoSil for the benefit of patients.\u202f<\/p>\n<p>The acquisition of the TachoSil manufacturing operations will benefit customers and employees, as TachoSil\u2019s experienced manufacturing teams and extensive production knowledge will be complemented by Corza Medical\u2019s surgical focus, global commercial expertise, entrepreneurial culture, and infrastructure to scale for significant growth.<\/p>\n<p>\u201cIn the last two years, we\u2019ve significantly expanded the number of surgeons using TachoSil worldwide. With this acquisition of the TachoSil production facility in Linz, we\u2019ve now assembled a critical piece of our growing Biosurgery business to tightly integrate customer demand with production fulfillment to provide an exceptional service experience,\u201d said Gregory T. Lucier, Corza Medical Executive Chairman.<\/p>\n<p>Corza Medical\u2019s exclusive ownership of TachoSil manufacturing will deliver exceptional value to customers by seamlessly combining manufacturing and quality with Corza Medical\u2019s commercial excellence engine; it will also accelerate enhanced service levels and support by directly controlling manufacturing priorities.<\/p>\n<p>\u201cWe look forward to welcoming the Takeda TachoSil operations team to Corza Medical to support our investment in expanding manufacturing capacity, testing systems, and R&amp;D facilities to develop new Biosurgery offerings,\u201d said Tom Testa, Corza Medical Chief Executive Officer. \u201cThis acquisition in Linz highlights our commitment to further our presence in Europe and to better serve our customers with an integrated team.\u201d<\/p>\n<p>Corza Medical is a portfolio company of GTCR, a leading private equity firm, which helped create and build the business alongside Gregory T. Lucier. In January 2021, GTCR and Lucier simultaneously acquired and merged Surgical Specialties Corporation and the TachoSil carve-out from Takeda Pharmaceutical. Corza further expanded its surgical platform into the ophthalmic surgery sector with the add-on acquisitions of Katena Products and Barron Precision Instruments.<\/p>\n<p>The transaction, which is subject to the satisfaction of certain anti-trust and FDI customary regulatory approvals, is expected to close by the first quarter of 2024.<\/p>\n<p>\n        <strong>About Corza Medical\u202f<\/strong><br \/>\n        <br \/>Corza Medical is a leading global manufacturer of innovative surgical technologies. With a global team of over 2,500 employees supporting clinicians, distributors, and medical device companies worldwide, Corza provides healthcare professionals a platform of surgical technologies with industry-leading brands, including Quill\u00ae barbed sutures, Sharpoint\u00ae Plus and Look\u2122 surgical sutures, Katena\u00ae reusable and Blink\u2122 single-use ophthalmic instruments, Sharpoint\u00ae ophthalmic, and the TachoSil\u00ae fibrin sealant patch. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iaLqX-XoqZ0PELqLbNwkZbQOkCp5o6KPfT1x5IRbAcm4Av_iK7dDpItV799o57srH5JU6yRArysm1a3WpbkP8w==\" rel=\"nofollow noopener\" target=\"_blank\">www.corza.com<\/a>.<\/p>\n<p>\n        <strong>About GTCR<\/strong>\u00a0<br \/>Founded in 1980, GTCR is a leading private equity firm that pioneered The Leaders Strategy\u2122 \u2013 finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through organic growth and strategic acquisitions. GTCR is focused on investing in transformative growth in companies in the Business &amp; Consumer Services, Financial Services &amp; Technology, Healthcare and Technology, Media &amp; Telecommunications sectors. Since its inception, GTCR has invested more than $24 billion in over 270 companies, and the firm currently manages $24 billion in equity capital. GTCR is based in Chicago with offices in New York and West Palm Beach. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QuHjRu4duysWeIiMKS3YA2aGrIqGnTjLuO5ks11tDJ4JKsMGP_wRA3XniEa4InDkjpx2h8l2s5HY12i0cBWPYGYJH2C1LbPn0ghvykrs13-d8DBDJrJeKO1hST4o5XnvkiHl9EuZ7_dCqgdJHXhkSQ==\" rel=\"nofollow noopener\" target=\"_blank\">www.gtcr.com<\/a>. Follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zSPosbaJpsn8cmkrZZmMRC3uUD3rULhmH2nnEbtaEEEJ9JVrwDMdCrPPgB3-TGBTGA4WYDxve1fB4e6H5NWpm-lVV5OM_3GREgr4y983Ou4UM2fFkxOmjCaD1skyD7vCGIfJ3QRU7IATWtpuXC5iZg==\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>\n        <strong><br \/>\n          <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ko5cDdqSJgE8_dQa0NWmYTHLAz-K6Sm94Uh_N-K_n-KWiBMFubxIK1P2VhZm1Netn0f1HUfEz-hJRRgrvflwuA==\" rel=\"nofollow noopener\" target=\"_blank\">media@corza.com<\/a><br \/>\n        <\/strong>\n      <\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTMyNyM1NTU2NjUzIzIyNTU0OTA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDE1Yzc0OWEtOGU4YS00MGU1LWI1NjUtNzMyMzQ4NjQ0YWQyLTEyNjcwMzk=\/tiny\/Corza-Medical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WESTWOOD, Mass., April 26, 2023 (GLOBE NEWSWIRE) &#8212; Corza Medical announced today that it has entered into a definitive agreement with a subsidiary of Takeda Pharmaceuticals Company (TSE:4502\/NYSE:TAK) (\u201cTakeda\u201d) to acquire the TachoSil manufacturing operations in Linz, Austria. Corza Medical had previously acquired the commercial product rights for TachoSil, a best-in-class surgical patch trusted by medical professionals worldwide, in January 2021. Corza Medical shares Takeda\u2019s commitment to patient care and has the experience and resources to continue investing in TachoSil for the benefit of patients.\u202f The acquisition of the TachoSil manufacturing operations will benefit customers and employees, as TachoSil\u2019s experienced manufacturing teams and extensive production knowledge will be complemented by Corza Medical\u2019s surgical focus, global commercial expertise, entrepreneurial culture, and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Corza Medical Signs Definitive Agreement to Acquire Takeda&#8217;s TachoSil Manufacturing Operations&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-751462","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Corza Medical Signs Definitive Agreement to Acquire Takeda&#039;s TachoSil Manufacturing Operations - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Corza Medical Signs Definitive Agreement to Acquire Takeda&#039;s TachoSil Manufacturing Operations - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WESTWOOD, Mass., April 26, 2023 (GLOBE NEWSWIRE) &#8212; Corza Medical announced today that it has entered into a definitive agreement with a subsidiary of Takeda Pharmaceuticals Company (TSE:4502\/NYSE:TAK) (\u201cTakeda\u201d) to acquire the TachoSil manufacturing operations in Linz, Austria. Corza Medical had previously acquired the commercial product rights for TachoSil, a best-in-class surgical patch trusted by medical professionals worldwide, in January 2021. Corza Medical shares Takeda\u2019s commitment to patient care and has the experience and resources to continue investing in TachoSil for the benefit of patients.\u202f The acquisition of the TachoSil manufacturing operations will benefit customers and employees, as TachoSil\u2019s experienced manufacturing teams and extensive production knowledge will be complemented by Corza Medical\u2019s surgical focus, global commercial expertise, entrepreneurial culture, and &hellip; Continue reading &quot;Corza Medical Signs Definitive Agreement to Acquire Takeda&#8217;s TachoSil Manufacturing Operations&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-26T15:21:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTMyNyM1NTU2NjUzIzIyNTU0OTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Corza Medical Signs Definitive Agreement to Acquire Takeda&#8217;s TachoSil Manufacturing Operations\",\"datePublished\":\"2023-04-26T15:21:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\\\/\"},\"wordCount\":585,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTMyNyM1NTU2NjUzIzIyNTU0OTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\\\/\",\"name\":\"Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTMyNyM1NTU2NjUzIzIyNTU0OTA=\",\"datePublished\":\"2023-04-26T15:21:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTMyNyM1NTU2NjUzIzIyNTU0OTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTMyNyM1NTU2NjUzIzIyNTU0OTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Corza Medical Signs Definitive Agreement to Acquire Takeda&#8217;s TachoSil Manufacturing Operations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/","og_locale":"en_US","og_type":"article","og_title":"Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations - Market Newsdesk","og_description":"WESTWOOD, Mass., April 26, 2023 (GLOBE NEWSWIRE) &#8212; Corza Medical announced today that it has entered into a definitive agreement with a subsidiary of Takeda Pharmaceuticals Company (TSE:4502\/NYSE:TAK) (\u201cTakeda\u201d) to acquire the TachoSil manufacturing operations in Linz, Austria. Corza Medical had previously acquired the commercial product rights for TachoSil, a best-in-class surgical patch trusted by medical professionals worldwide, in January 2021. Corza Medical shares Takeda\u2019s commitment to patient care and has the experience and resources to continue investing in TachoSil for the benefit of patients.\u202f The acquisition of the TachoSil manufacturing operations will benefit customers and employees, as TachoSil\u2019s experienced manufacturing teams and extensive production knowledge will be complemented by Corza Medical\u2019s surgical focus, global commercial expertise, entrepreneurial culture, and &hellip; Continue reading \"Corza Medical Signs Definitive Agreement to Acquire Takeda&#8217;s TachoSil Manufacturing Operations\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-26T15:21:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTMyNyM1NTU2NjUzIzIyNTU0OTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Corza Medical Signs Definitive Agreement to Acquire Takeda&#8217;s TachoSil Manufacturing Operations","datePublished":"2023-04-26T15:21:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/"},"wordCount":585,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTMyNyM1NTU2NjUzIzIyNTU0OTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/","name":"Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTMyNyM1NTU2NjUzIzIyNTU0OTA=","datePublished":"2023-04-26T15:21:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTMyNyM1NTU2NjUzIzIyNTU0OTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTMyNyM1NTU2NjUzIzIyNTU0OTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corza-medical-signs-definitive-agreement-to-acquire-takedas-tachosil-manufacturing-operations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Corza Medical Signs Definitive Agreement to Acquire Takeda&#8217;s TachoSil Manufacturing Operations"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/751462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=751462"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/751462\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=751462"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=751462"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=751462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}